Kalshi· Science and Technology

When will FDA announce Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List?

Chance

—

Buy Yes

—

pays $1 if it happens

Buy No

—

pays $1 if it doesn’t

Prices from Kalshi, updated 1 minute ago. Ends Sep 1, 3:59 AM UTC.

Price over the last 2 weeks

Cost of a Yes share

How this market is decidedShow

If the FDA announces Reclassification of BPC-157 to Category 1 of the Bulk Drug Substances List before Sep 1, 2026, then the market resolves to Yes. The Payout Criterion is satisfied by placement of BPC-157 in either Category 1 or Category 1 Bulk Drug Substances Under Evaluation on the 503A Bulk Drug Substances list, as either designation restores compounding eligibility. Removal from Category 2 alone, without placement in Category 1, does not satisfy the Payout Criterion.